Key Sessions
Niklas Engler
Keynote: Next Generation Process Development and Manufacturing for Cell and Gene Therapies – Improving Efficiencies and Reducing Cost of Goods
Roche
Thomas M. Spitznagel
KEYNOTE: Strategies for Development, Manufacturing, and Supply Chain to Support a Diverse Pipeline
Macrogenics
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Day One - CET/CEST (Cent Europe Summer, GMT+2)
keyboard_arrow_leftSearch & Filter
search
Streams
Day One - CET/CEST (Cent Europe Summer, GMT+2)
search
Streams
08:00 - 08:5555 mins
Coffee and Registration
08:55 - 09:005 mins
Cell Line Development & Engineering
Chairperson's Opening Remarks
08:55 - 09:005 mins
Cell Culture & Upstream Processing
Chairperson's Opening Remarks
08:55 - 09:005 mins
Downstream Processing
Chairperson's Opening Remarks
- Fausto Artico - Global R&D Tech Head of Innovation and Data Science, GSK, UK
08:55 - 09:005 mins
Manufacturing & Industry 4.0
Chairperson's Opening Remarks
- Swapnil Bhargava - Senior Vice President, CMC Development and GMP Manufacturing, AbCellera
08:55 - 09:005 mins
Cell & Gene Therapy
Chairperson's Opening Remarks
09:00 - 09:3030 mins
Cell Line Development & Engineering
KEYNOTE: New synthetic genetic parts and engineering systems for biologics production
- David James - Professor of Bioprocess Engineering, University of Sheffield
09:00 - 09:3030 mins
Cell Culture & Upstream Processing
Found in Translation: Mircoproteins, are a New Class of Potential Host Cell Impurity in mAb Drug Products
- Colin Clarke, Ph.D. - SFI Principal Investigator, NIBRT
09:00 - 09:3030 mins
Downstream Processing
Using Artificial Intelligence and Molecular Simulations to Inform Process Design and Product Design
- Camille Bilodeau, PhD - Postdoctoral Researcher, University of Virginia
09:00 - 09:3030 mins
Manufacturing & Industry 4.0
KEYNOTE: Manufacturing Strategies for a Growing and Diverse Biologics Pipeline
- Felix Oehme - VP, Head of Biotech Strategy, Bayer Pharmaceuticals
09:00 - 09:3030 mins
Cell & Gene Therapy
Cell Line Development and Plasmid Optimization to Improve AAV Titers
- Ping Liu - Associate Director, Head of Cell Line Development, REGENXBIO Inc.
09:30 - 10:0030 mins
Cell Line Development & Engineering
Understanding the role of ubiquitination in ER stress mechanisms in recombinant CHO cells using LC-MS/MS
- Paula Meleady - Principal Investigator, Dublin City University
09:30 - 10:0030 mins
Cell Culture & Upstream Processing
Automated Online Monitoring of Glycosylation and Post-translation Modifications of Monoclonal Antibodies during Cell Culture Process
- Matthew Radle - Scientist, Analytical Sciences, AstraZeneca
09:30 - 10:0030 mins
Downstream Processing
Protein Refolding Optimization Using Model Predictive Control
- Christoph Herwig - Full Professor for Biochemical Engineers/Senior Advisor, TU WIEN/Körber Pharma Austria.GmbH
09:30 - 10:0030 mins
Manufacturing & Industry 4.0
EHS presentations - risk assessment of cells and safety data sheets
09:30 - 10:0030 mins
Cell & Gene Therapy
Development of a Serum-Free Lentivirus Production Platform Using Stable Producer Cell Lines
- Maximilian Klimpel - PhD Student Viral Vector Process Development, CSL Behring
10:00 - 10:3030 mins
Cell Line Development & Engineering
Scientific Track Presentation
10:00 - 10:3030 mins
Cell Culture & Upstream Processing
Scientific Track Presentation
10:00 - 10:3030 mins
Downstream Processing
Scientific Track Presentation
10:00 - 10:3030 mins
Manufacturing & Industry 4.0
Scientific Track Presentation - A Representative from Sartorius
10:00 - 10:3030 mins
Cell & Gene Therapy
Exploring the Potential of AAV-Based Gene Therapy: Advances and Challenges
- Roland Leathers - Senior Strategic Alliances Manager, Cell & Gene Therapy, Thermo Fisher Scientific
10:30 - 11:0030 mins
Morning Coffee Break
11:00 - 11:3030 mins
Cell Line Development & Engineering
Enhancing stability of recombinant CHO cells by site-specific integration into regions with distinct histone modifications
- Oliver Hertel - Postdoctoral Researcher, Cell Culture Technology Group, Bielefeld University
11:00 - 11:3030 mins
Cell Culture & Upstream Processing
Machine Learning Integration In Cell Line Screening Pipeline
- Tobias Großkopf - Senior Scientist, Roche
11:00 - 11:3030 mins
Downstream Processing
Creating Novel Milliliter and Microliter Scale-Down Models of a Connected Chromatography Process
- Julian Hitzler - Senior Expert Science & Technology, Drug Substance Development, Novartis Pharma
11:00 - 11:3030 mins
Manufacturing & Industry 4.0
Outsourcing Biologics CMC Development & Manufacturing – A Big Pharma Perspective
- Ulrich Ruemenapp - Head of Launch Preparation, Bayer AG
11:00 - 11:3030 mins
Cell & Gene Therapy
Advancing the Productivity, Robustness, and Scalability of AAV Production Process by Transient Transfection in Suspension Cell Culture
- Jenny Shupe - Head of Gene Therapy Upstream Process Development, Biogen
11:30 - 12:0030 mins
Cell Line Development & Engineering
Keynote: A Novel System for Glycosylation Engineering by Natural and Artificial miRNAs
- Kerstin Otte, PhD - Professor, Hochschule Biberach
11:30 - 12:0030 mins
Cell Culture & Upstream Processing
Strategy for Upstream Process Data Integration
- Curtis Lin, PhD - Associate Director, Data Science, Seattle Genetics
11:30 - 12:0030 mins
Downstream Processing
Big Data Analytics for Control of Continuous Processes
- Anurag Rathore, Ph.D. - Coordinator, DBT COE for Biopharmaceutical Technology, Professor, Department of Chemical Engineering, Indian Institute of Technology
11:30 - 12:0030 mins
Manufacturing & Industry 4.0
Digital Bioprocess Twins: Enablers for accelerated process development and model predictive control strategies
- Mark Duerkop - Chief Executive Officer, Novasign
11:30 - 12:0030 mins
Cell & Gene Therapy
High-Throughput Scale-Down Model For Fast USP Development In Gene Therapy
- Hugo F. Cueto-Rojas - Lead Scientist USP Development, uniQure
12:00 - 12:3030 mins
Cell Line Development & Engineering
Scientific Track Presentation - A Representative from Advanced Instruments
12:00 - 12:3030 mins
Cell Culture & Upstream Processing
Help maximize high-density cell expansion with sustainable single-use bioreactors
- Wouter Palmaerts - Senior Field Application Specialist, Thermo Fisher Scientific
12:00 - 12:3030 mins
Downstream Processing
Scientific Track Presentation - A Representative from 3M
12:00 - 12:3030 mins
Manufacturing & Industry 4.0
How to perform accelerated process characterization and save 50% of the experiments
- Barbara Pretzner - Senior Consultant, Körber Pharma Austria GmbH
12:00 - 12:1515 mins
Cell & Gene Therapy
Scientific Track Presentation - A Representative from Batavia
12:15 - 12:3015 mins
Cell & Gene Therapy
Scientific Track Presentation - A Representative from Polyplus
12:30 - 13:4070 mins
Lunch and Sponsored Lunch Presentations
13:40 - 13:455 mins
Cell Line Development & Engineering
Chairperson Remarks
13:40 - 13:455 mins
Cell Culture & Upstream Processing
Chairperson Remarks
13:40 - 13:455 mins
Downstream Processing
Chairperson’s Remarks
- Paul Dunne - Business Development Specialist, Research Center Pharmaceutical Engineering GmbH
13:40 - 13:455 mins
Manufacturing & Industry 4.0
Chairperson's Remarks
- Fausto Artico - Global R&D Tech Head of Innovation and Data Science, GSK, UK
13:40 - 13:455 mins
Cell & Gene Therapy
Chairperson Remarks
13:45 - 14:1530 mins
Cell Line Development & Engineering
The Power of Transposases: How an Ancient Cellular Mechanism Revolutionized Modern Biopharmaceutical Development
- Patrick Schulz, PhD - Director Cell Line Development, Biologicals Development, Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
13:45 - 14:1530 mins
Cell Culture & Upstream Processing
In the Development of a Biosimilar, How Much Clonal Variation Do You Get in Glycosylation Patterns?
- Susan Sharfstein, PhD - Professor of Nanobioscience, College of Nanoscale Science and Engineering, SUNY Polytechnic Institute
13:45 - 14:1530 mins
Downstream Processing
Using Flow PPX for Continuous Processing
- Aishwarya Ramanan - Senior Research Associate, Purification, Seattle Genetics
13:45 - 14:4560 mins
Manufacturing & Industry 4.0
Panel Discussion: Designing The Facility of the Future
- Fausto Artico - Global R&D Tech Head of Innovation and Data Science, GSK, UK
- Mark Duerkop - Chief Executive Officer, Novasign
- Tarik Senussi - Snr Director of Process, Formulation Development & MSAT, Gyroscope Therapeutics
- Mohamed Chtaini - Exec. Director, Global Biologics External Collaborations & MFG Global Technical Operations, Incyte
13:45 - 14:1530 mins
Cell & Gene Therapy
Implementing Continuous Processing for CGT
- Manuel Carrondo - Prof. Chemical & Biochemical Engineering, Vice-President iBET, iBET
14:15 - 14:4530 mins
Cell Line Development & Engineering
Panel Discussion: Targeted versus Transposase versus Random Integration
- Kiavash Mirzadeh, PhD - Senior Scientist, Xbrane Biopharma
- Oliver Hertel - Postdoctoral Researcher, Cell Culture Technology Group, Bielefeld University
- Patrick Schulz, PhD - Director Cell Line Development, Biologicals Development, Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
- Oren Beske, Ph.D. - Amalgamator of Business and Biology, ATUM
14:15 - 14:4530 mins
Cell Culture & Upstream Processing
Economic Analysis of Vaccine Manufacture for Pandemic Preparedness
- Chris Stamatis, EngD - Research Associate, Department of Biochemical Engineering, UCL
14:15 - 14:4530 mins
Downstream Processing
Smart Platform for Fast Development of Small-Scale Integrated Continuous Downstream Processes
- Bernt Nilsson, Ph.D. - Professor, Chemical Engineering, Lund University
14:15 - 14:4530 mins
Cell & Gene Therapy
Evaluating New Technologies to Overcome Downstream Processing Challenges -Increase Titres and Reducing Cost of Goods
14:45 - 15:1530 mins
Cell Line Development & Engineering
Scientific Track Presentation - A Representative from Cergentis
14:45 - 15:1530 mins
Cell Culture & Upstream Processing
Scientific Track Presentation - A Representative from Merck
14:45 - 15:0015 mins
Downstream Processing
Mass Photometry: A Fast and Accurate Mass Characterisation of Biomolecules
- Racha Majed - Technical Specialist, Refeyn
14:45 - 15:1530 mins
Manufacturing & Industry 4.0
Scientific Track Presentation
14:45 - 15:1530 mins
Cell & Gene Therapy
Viral Clearance in Cell & Gene Therapy – What if the Product is a Virus?
- Sandra Meier - Viral Clearance R&D Scientist, Biologics Testing Solutions, Charles River
15:00 - 15:1515 mins
Downstream Processing
Advantages of Mixed mode chromatography in host cell protein removal
- Thomas Valorose - Sr. Product Manager, Astrea Bioseparations
15:15 - 15:4530 mins
Networking Refreshment Break
15:45 - 15:505 mins
Plenary Sessions
Chairperson's Remarks
15:50 - 16:2535 mins
Plenary Sessions
Keynote: Next Generation Process Development and Manufacturing for Cell and Gene Therapies – Improving Efficiencies and Reducing Cost of Goods
- Niklas Engler - Global Head Technical Development Portfolio and Projects, VP, Roche
16:25 - 17:0035 mins
Plenary Sessions
KEYNOTE: Strategies for Development, Manufacturing, and Supply Chain to Support a Diverse Pipeline
- Thomas M. Spitznagel - Sr. Vice President, Technical Operations, Macrogenics
17:00 - 18:3090 mins
Cocktail Reception and Grand Opening of Exhibit & Poster Hall
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams